BFA
DRTX

BlackRock Fund Advisors’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

BlackRock Fund Advisors’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-374,262
Closed -$4.75M – 3960
2014
Q3 		$4.75M Sell
374,262
-6,442
-2% -$96.2K ﹤0.01% 2785
2014
Q2 		$6.48M Buy
380,704
+9,924
+3% +$148K ﹤0.01% 2686
2014
Q1 		$4.99M Buy
370,780
+15,474
+4% +$203K ﹤0.01% 2818
2013
Q4 		$4.54M Sell
355,306
-16,063
-4% -$168K ﹤0.01% 2888
2013
Q3 		$3.36M Buy
371,369
+42,989
+13% +$357K ﹤0.01% 3013
2013
Q2 		$2.36M Buy
+328,380
New +$2.41M ﹤0.01% 3064

BlackRock Fund Advisors's DRTX Position: Q4 2014 in Review

BlackRock Fund Advisors sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 374,262 shares — an estimated $4.75M sold.

BlackRock Fund Advisors first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $6.48M in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • BlackRock Fund Advisors reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • BlackRock Fund Advisors sold 374,262 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $4.75M.
  • BlackRock Fund Advisors first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • BlackRock Fund Advisors's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $6.48M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on BlackRock Fund Advisors's 13F filing for Q4 2014, filed 9 Feb 2015.